Cardiac 123I-MIBG scintigraphy and arrhythmic risk in left ventricular noncompaction

Revista Portuguesa de Cardiologia

Volumn 31, Issue 3, 2012, Pages 247-250

  Oliveira, Sílvia Marta ^a,b   Martins, Elisabete ^a,b   Oliveira, Ana ^a   Pinho, Teresa ^a,b   Gavina, Cristina ^a,b   Faria, Teresa ^a   Silva Cardoso, José Carlos ^a,b   Pereira, Jorge ^a   Maciel, Maria Júlia ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Arrhythmias; Left ventricular noncompaction

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; EXERCISE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; VENTRICULAR NONCOMPACTION; RISK FACTOR; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADULT; ARRHYTHMIAS, CARDIAC; HUMANS; IODINE RADIOISOTOPES; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; MALE; RADIOPHARMACEUTICALS; RISK FACTORS;

EID: 84860585489     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.01.002     Document Type: Article

References (12)

1. Freedom RM, Yoo SJ, Perrin D, et al. The morphological spectrum of ventricular noncompaction. Cardiol Young. 2005;15:345-64.
2. Bartram U, Bauer J, Schranz D. Primary noncompaction of the ventricular myocardium from the morphogenetic standpoint. Pediatr Cardiol. 2007;28:325-32.
3. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36:493-500.
4. Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666-71.
5. Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol. 2002;90:899-902.
6. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101-5.
7. Caliskan K, Szili-Torok T, Theuns DA, et al. Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:898-904.
8. Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535-46.
9. 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147-59.
10. Tamaki S, Yamada T, Okuyama Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol. 2009;53:426-35.
11. Katoh S, Shishido T, Kutsuzawa D, et al. Iodine-123- metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction. Ann Nucl Med. 2010;24:679-86.
12. Kaneda T, Shimizu M, Ino H, et al. Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium. Circulation. 2005;112:e96-7.